Who owns Compass Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of CMPX from SEC Form 13F filings across 172 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 172 institutions disclosed 160.6M shares of Compass Therapeutics, Inc. worth $167.0M — about 86% of shares outstanding; the largest disclosed holder is TANG CAPITAL MANAGEMENT LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
172
13F holders
$167.0M
value, 2026 filers
86%
of shares outstanding (160.6M sh)
21
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of CMPX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | TANG CAPITAL MANAGEMENT LLC | 18.0M | $18.7M | 0.9% | 9.6% | 0.0% |
| 2 | ORBIMED ADVISORS LLC | 15.2M | $15.8M | 0.3% | 8.1% | 0.0% |
| 3 | MONTANOVA CAPITAL, LLC | 14.3M | $14.9M | 0.3% | 7.7% | +1.6% |
| 4 | BlackRock, Inc. | 11.4M | $11.9M | 0.0% | 6.1% | +1.0% |
| 5 | ENAVATE SCIENCES GP, LLC | 7.8M | $8.1M | 2.9% | 4.2% | 0.0% |
| 6 | STATE STREET CORP | 7.7M | $8.0M | 0.0% | 4.1% | -22.3% |
| 7 | Palo Alto Investors LP | 7.1M | $7.4M | 1.1% | 3.8% | +22.6% |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | 6.0M | $6.2M | 0.0% | 3.2% | -2.0% |
| 9 | MILLENNIUM MANAGEMENT LLC | 4.7M | $4.9M | 0.0% | 2.5% | -0.6% |
| 10 | Qube Research & Technologies Ltd | 4.2M | $4.3M | 0.0% | 2.2% | +13.1% |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | 3.6M | $3.8M | 0.0% | 2% | -4.5% |
| 12 | Rock Springs Capital Management LP | 3.5M | $3.7M | 0.2% | 1.9% | 0.0% |
| 13 | Vivo Capital, LLC | 3.4M | $3.6M | 0.4% | 1.8% | -55.9% |
| 14 | GOLDMAN SACHS GROUP INC | 3.4M | $3.5M | 0.0% | 1.8% | -3.9% |
| 15 | Blue Owl Capital Holdings LP | 3.2M | $3.3M | 0.6% | 1.7% | -13.0% |
| 16 | HRT FINANCIAL LP | 2.7M | $2.8M | 0.0% | 1.4% | +1465.2% |
| 17 | ACADIAN ASSET MANAGEMENT LLC | 2.6M | $2.7M | 0.0% | 1.4% | +127.0% |
| 18 | CITADEL ADVISORS LLC | 2.1M | $2.2M | 0.0% | 1.1% | -40.1% |
| 19 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2.1M | $2.2M | 0.0% | 1.1% | -44.9% |
| 20 | AQR CAPITAL MANAGEMENT LLC | 2.0M | $2.1M | 0.0% | 1.1% | -43.7% |
| 21 | Fisher Asset Management, LLC | 1.9M | $2.0M | 0.0% | 1% | +39.8% |
| 22 | FMR LLC | 1.8M | $1.9M | 0.0% | 1% | +48.3% |
| 23 | D. E. Shaw & Co., Inc. | 1.7M | $1.8M | 0.0% | 0.9% | +754.0% |
| 24 | MARSHALL WACE, LLP | 1.7M | $1.8M | 0.0% | 0.9% | +409.8% |
| 25 | Birchview Capital, LP | 1.6M | $1.6M | 0.9% | 0.8% | -6.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.